Travis J Carlson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 23

Top Topics

Clostridium Difficile

Clinical Practice

Top Venues

JAC-antimicrobial resistance

Open forum infectious diseases

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, Travis J Carlson, Faris Alnezary, William R Miller, Aki Sakurai, An Q Dinh, Kirsten Rydell, Rafael Rios, Lorena Diaz, Blake M Hanson, Jose M Munita, Claudia Pedroza, Samuel A Shelburne Iii, Samuel L Aitken, Kevin W Garey, Ryan Dillon, Laura Puzniak, Cesar A Arias
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-antimicrobial resistance 5 (1) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs (2023)
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, Travis J Carlson, Faris Alnezary, William R Miller, Aki Sakurai, An Q Dinh, Kirsten Rydell, Rafael Rios, Lorena Diaz, Blake M Hanson, Jose M Munita, Claudia Pedroza, Samuel A Shelburne Iii, Samuel L Aitken, Kevin W Garey, Ryan Dillon, Laura Puzniak, Cesar A Arias
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-antimicrobial resistance 5 (1) (2023)
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, Travis J Carlson, Faris Alnezary, William R Miller, Aki Sakurai, An Q Dinh, Kirsten Rydell, Rafael Rios, Lorena Diaz, Blake M Hanson, Jose M Munita, Claudia Pedroza, Samuel A Shelburne Iii, Samuel L Aitken, Kevin W Garey, Ryan Dillon, Laura Puzniak, Cesar A Arias
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-antimicrobial resistance 5 (1) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Denise Marie A Francisco, Laila Woc-Colburn, Travis J Carlson, Todd Lasco, Miriam Barrett, Mayar Al Mohajer
The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective study. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, Travis J Carlson, Faris Alnezary, William R Miller, Aki Sakurai, An Q Dinh, Kirsten Rydell, Rafael Rios, Lorena Diaz, Blake M Hanson, Jose M Munita, Claudia Pedroza, Samuel A Shelburne Iii, Samuel L Aitken, Kevin W Garey, Ryan Dillon, Laura Puzniak, Cesar A Arias
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-antimicrobial resistance 5 (1) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies. Gut microbes 15 (1) (2023)
Denise Marie A Francisco, Laila Woc-Colburn, Travis J Carlson, Todd Lasco, Miriam Barrett, Mayar Al Mohajer
The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective study. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs 83 (2) (2023)
Eric H Young, Kelsey A Strey, Grace C Lee, Travis J Carlson, Jim M Koeller, Vidal M Mendoza, Kelly R Reveles
National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016. Antibiotics (Basel, Switzerland) 12 (1) (2022)
Eric H Young, Kelsey A Strey, Grace C Lee, Travis J Carlson, Jim M Koeller, Kelly R Reveles
Clostridioides difficile Infection Treatment and Outcome Disparities in a National Sample of United States Hospitals. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Eric H Young, Kelsey A Strey, Grace C Lee, Travis J Carlson, Jim M Koeller, Vidal M Mendoza, Kelly R Reveles
National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016. Antibiotics (Basel, Switzerland) 12 (1) (2022)
Travis J Carlson, Anne J Gonzales-Luna, Melissa F Wilcox, Sarah G Theriault, Faris S Alnezary, Pankaj Patel, Bumhee K Ahn, Evan J Zasowski, Kevin W Garey
Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use. Open forum infectious diseases 8 (10) (2021)
Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, Marco R Scipione, Jing J Zhao, Sarah C J Jorgensen, Ryan Mynatt, Travis J Carlson, Jinhee Jo, Kevin W Garey, David Allen, Kailynn DeRonde, Ana D Vega, Lilian M Abbo, Veena Venugopalan, Vasilios Athans, Stephen Saw, Kimberly C Claeys, Mathew Miller, Kyle C Molina, Michael Veve, Wesley D Kufel, Lee Amaya, Christine Yost, Jessica Ortwine, Susan L Davis, Michael Joseph Rybak
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. Open forum infectious diseases 8 (8) (2021)
Anne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Antibiotic Therapies for Clostridioides difficile Infection in Children. Journal of the Pediatric Infectious Diseases Society 10 (Supplement_3) (2021)
Nicholas Rebold, Michael J Rybak, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie E Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark J Biagi, Wesley D Kufel, William J Moore, Nicholas J Mercuro, Brian R Raux, Michael Joseph Rybak
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open forum infectious diseases 8 (12) (2021)
Allison N Tucker, Travis J Carlson, Aurijit Sarkar
Challenges in Drug Discovery for Intracellular Bacteria. Pathogens (Basel, Switzerland) 10 (9) (2021)